Johnson & Johnson Launches Rybrevant in China for EGFR Exon 20 Insertion Mutation Lung Cancer
CompanyDrug

Johnson & Johnson Launches Rybrevant in China for EGFR Exon 20 Insertion Mutation Lung Cancer

Tasly Pharma Gains NMPA Green Light for CAR-T Therapy Clinical Study in Recurrent Glioblastoma
CompanyDrug

Tasly Pharma Gains NMPA Green Light for CAR-T Therapy Clinical Study in Recurrent Glioblastoma

CR Boya Gains NMPA Approval for Clinical Trials of Subcutaneous Human Immunoglobulin
CompanyDrug

CR Boya Gains NMPA Approval for Clinical Trials of Subcutaneous Human Immunoglobulin

Novartis Announces USD 23 Billion Investment to Expand U.S. Manufacturing and R&D Hubs
Company

Novartis Announces USD 23 Billion Investment to Expand U.S. Manufacturing and R&D Hubs

Juventas Cell Therapy Secures China Clinical Trial Approval for Inaticabtagene Autoleucel in AIHA
CompanyDrug

Juventas Cell Therapy Secures China Clinical Trial Approval for Inaticabtagene Autoleucel in AIHA

Belief BioMed and Takeda Win NMPA Approval for China's First Hemophilia B Gene Therapy
CompanyDrug

Belief BioMed and Takeda Win NMPA Approval for China’s First Hemophilia B Gene Therapy

Zai Lab's Partner argenx Secures FDA Approval for Vygart Hytrulo Prefilled Syringe in gMG and CIDP
CompanyDrug

Zai Lab’s Partner argenx Secures FDA Approval for Vygart Hytrulo Prefilled Syringe in gMG and CIDP

Pierre Fabre and Red Ridge Bio Partner on Biparatopic Antibody Development for Precision Oncology
CompanyDeals

Pierre Fabre and RedRidge Bio Partner on Biparatopic Antibody Development for Precision Oncology

INTCO Medical and JD Healthcare Partner to Innovate 'Internet + Healthcare' Service Models
CompanyDeals

INTCO Medical and JD Healthcare Partner to Innovate ‘Internet + Healthcare’ Service Models

KingstronBio's Prostyle A Valve Gains NMPA Approval, Setting New Benchmark in Transcatheter Aortic Valve Replacement
CompanyMedical Device

KingstronBio’s Prostyle A Valve Gains NMPA Approval, Setting New Benchmark in Transcatheter Aortic Valve Replacement

iRegene Therapeutics Secures RMB 100 Million in Series B+ Financing to Advance iPSC Technology
CompanyDeals

iRegene Therapeutics Secures RMB 100 Million in Series B+ Financing to Advance iPSC Technology

Novo Nordisk Invests BRL 6.4 Billion in Brazilian Manufacturing Expansion for Obesity Drugs
Company

Novo Nordisk Invests BRL 6.4 Billion in Brazilian Manufacturing Expansion for Obesity Drugs